Healthcare and Pharmaceuticals industry

Osteoarthritis Drugs Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Osteoarthritis Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Osteoarthritis is also termed as degenerative arthritis and is commonly a chronic disease that affects the joints in the hips, knees, and neck. In this condition cartilage that provides support and gliding surface for joints during movement gets breakdown which leads to pain and swelling in the affected area. Osteoarthritis drugs are used to relived pain caused due to osteoarthritis.

The growing prevalence of osteoarthritis around the globe is predominantly fueling market growth. According to the World Health Organization, worldwide estimates show that 9.6% of men and 18.0% of women aged over 60 years have symptomatic osteoarthritis. 80% of those with osteoarthritis will have limitations in movement, and 25% cannot perform their major daily activities of life. On the other hand, side-effects associated with the drugs and loss of patent of branded therapies is projected to hamper the market growth of the osteoarthritis drugs.

North America is expected to gain significant growth over the forecast period and this is attributed to the presence of a well-established healthcare industry coupled with the continuous product innovation by major players in the region. For instance, in July 2019, Teva Pharmaceutical Industries Ltd. announced the launch of 1% Sodium Hyaluronate. The product received approval from the Center for Devices and Radiological Health of the U.S. Food and Drug Administration. 1% Sodium Hyaluronate is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients.

Key Developments:

  • In December 2019, Flexion Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the product label for ZILRETTA (triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis (OA) knee pain.
  • In December 2019, The US Food and Drug Administration (FDA) has approved RediTrex, produced by Cumberland Pharmaceuticals. Methotrexate products designed for the treatment of adult and pediatric patients with rheumatoid arthritis, as well as adults with psoriasis.
  • In February 2020, NUI Galway launched a €7.45m research project into osteoarthritis. The €7.45m AutoCRAT project will enable researchers to develop innovative scientific and engineering platforms to produce advanced cellular therapeutics for use in the treatment of osteoarthritis and other major diseases.
  • In May 2020, Teva and Celltrion Healthcare announce the launch of TRUXIMA® (rituximab-abbs) injection for rheumatoid arthritis, the Only Biosimilar to Rituxan® (rituximab) Available in the United States
  • In October 2018, Eli Lilly and Company (India) Pvt Ltd announced the launch of Olumiant (baricitinib). Olumiant (baricitinib) is a once-daily oral medication for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA).

The Osteoarthritis Drugs Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Osteoarthritis Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Johnson & Johnson
  • Pfizer
  • Eli Lilly
  • Abbott
  • GlaxoSmithKline
  • Sanofi
  • Flexion Therapeutics
  • ...

By the Product Type, the market is primarily segmented into:

  • Oral
  • Injection
  • External

By Applications, the market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Osteoarthritis Drugs Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Osteoarthritis Drugs Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Osteoarthritis Drugs Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact the growth of the Osteoarthritis Drugs Market

The Osteoarthritis Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Osteoarthritis Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type, and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into the specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Osteoarthritis Drugs Market Overview
1.1 Product Overview and Scope of Osteoarthritis Drugs
1.2 Osteoarthritis Drugs Segment by Type
1.2.1 Global Osteoarthritis Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Drugs Segment by Application
1.3.1 Osteoarthritis Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Osteoarthritis Drugs Market by Region
1.4.1 Global Osteoarthritis Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Osteoarthritis Drugs Market Size
1.5.1 Global Osteoarthritis Drugs Revenue (2014-2025)
1.5.2 Global Osteoarthritis Drugs Production (2014-2025)

2 Global Osteoarthritis Drugs Market Competition by Manufacturers
2.1 Global Osteoarthritis Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Osteoarthritis Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Osteoarthritis Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Osteoarthritis Drugs Production Sites, Area Served, Product Types
2.5 Osteoarthritis Drugs Market Competitive Situation and Trends
2.5.1 Osteoarthritis Drugs Market Concentration Rate
2.5.2 Osteoarthritis Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Osteoarthritis Drugs Production Market Share by Regions
3.1 Global Osteoarthritis Drugs Production Market Share by Regions
3.2 Global Osteoarthritis Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Osteoarthritis Drugs Production
3.4.1 North America Osteoarthritis Drugs Production Growth Rate (2014-2019)
3.4.2 North America Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Osteoarthritis Drugs Production
3.5.1 Europe Osteoarthritis Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Osteoarthritis Drugs Production
3.6.1 China Osteoarthritis Drugs Production Growth Rate (2014-2019)
3.6.2 China Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Osteoarthritis Drugs Production
3.7.1 Japan Osteoarthritis Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Osteoarthritis Drugs Consumption by Regions
4.1 Global Osteoarthritis Drugs Consumption by Regions
4.2 North America Osteoarthritis Drugs Consumption (2014-2019)
4.3 Europe Osteoarthritis Drugs Consumption (2014-2019)
4.4 China Osteoarthritis Drugs Consumption (2014-2019)
4.5 Japan Osteoarthritis Drugs Consumption (2014-2019)

5 Global Osteoarthritis Drugs Production, Revenue, Price Trend by Type
5.1 Global Osteoarthritis Drugs Production Market Share by Type (2014-2019)
5.2 Global Osteoarthritis Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Osteoarthritis Drugs Price by Type (2014-2019)
5.4 Global Osteoarthritis Drugs Production Growth by Type (2014-2019)

6 Global Osteoarthritis Drugs Market Analysis by Applications
6.1 Global Osteoarthritis Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Osteoarthritis Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Osteoarthritis Drugs Business
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Osteoarthritis Drugs Production Sites and Area Served
7.1.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.1.3 Johnson & Johnson Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Pfizer
7.2.1 Pfizer Osteoarthritis Drugs Production Sites and Area Served
7.2.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.2.3 Pfizer Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Eli Lilly
7.3.1 Eli Lilly Osteoarthritis Drugs Production Sites and Area Served
7.3.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.3.3 Eli Lilly Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Abbott
7.4.1 Abbott Osteoarthritis Drugs Production Sites and Area Served
7.4.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.4.3 Abbott Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Osteoarthritis Drugs Production Sites and Area Served
7.5.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.5.3 GlaxoSmithKline Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Sanofi
7.6.1 Sanofi Osteoarthritis Drugs Production Sites and Area Served
7.6.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.6.3 Sanofi Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Flexion Therapeutics
7.7.1 Flexion Therapeutics Osteoarthritis Drugs Production Sites and Area Served
7.7.2 Osteoarthritis Drugs Product Introduction, Application and Specification
7.7.3 Flexion Therapeutics Osteoarthritis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served

8 Osteoarthritis Drugs Manufacturing Cost Analysis
8.1 Osteoarthritis Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Osteoarthritis Drugs
8.4 Osteoarthritis Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Osteoarthritis Drugs Distributors List
9.3 Osteoarthritis Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Osteoarthritis Drugs Market Forecast
11.1 Global Osteoarthritis Drugs Production, Revenue Forecast
11.1.1 Global Osteoarthritis Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Osteoarthritis Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Osteoarthritis Drugs Price and Trend Forecast (2019-2025)
11.2 Global Osteoarthritis Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Osteoarthritis Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Osteoarthritis Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Osteoarthritis Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Osteoarthritis Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Osteoarthritis Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Osteoarthritis Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Osteoarthritis Drugs Consumption Forecast (2019-2025)
11.3.3 China Osteoarthritis Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Osteoarthritis Drugs Consumption Forecast (2019-2025)
11.4 Global Osteoarthritis Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Osteoarthritis Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures

Figure Picture of Osteoarthritis Drugs
Table Global Osteoarthritis Drugs Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Osteoarthritis Drugs Production Market Share by Types in 2018
Figure Oral Product Picture
Table Oral Major Manufacturers
Figure Injection Product Picture
Table Injection Major Manufacturers
Figure External Product Picture
Table External Major Manufacturers
Table Global Osteoarthritis Drugs Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Osteoarthritis Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Table Osteoarthritis Drugs Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Osteoarthritis Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Osteoarthritis Drugs Revenue (Million USD) (2014-2025)
Figure Global Osteoarthritis Drugs Production (MT) (2014-2025)
Table Global Osteoarthritis Drugs Production (MT) of Key Manufacturers (2014-2019)
Table Global Osteoarthritis Drugs Production Share by Manufacturers (2014-2019)
Figure Osteoarthritis Drugs Production Share by Manufacturers in 2018
Table Global Osteoarthritis Drugs Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Osteoarthritis Drugs Revenue Share by Manufacturers (2014-2019)
Figure Global Osteoarthritis Drugs Revenue Share by Manufacturers in 2018
Table Global Market Osteoarthritis Drugs Average Price (USD/Kg) of Key Manufacturers (2014-2019)
Figure Global Market Osteoarthritis Drugs Average Price (USD/Kg) of Key Manufacturers in 2018
Table Manufacturers Osteoarthritis Drugs Production Sites and Area Served
Table Manufacturers Osteoarthritis Drugs Product Types
Figure Osteoarthritis Drugs Market Share of Top 5 Manufacturers
Figure Osteoarthritis Drugs Market Share of Top 10 Manufacturers
Table Global Osteoarthritis Drugs Production (MT) by Region (2014-2019)
Table Global Osteoarthritis Drugs Production Market Share by Region (2014-2019)
Figure Global Osteoarthritis Drugs Production Market Share by Region (2014-2019)
Figure Global Osteoarthritis Drugs Production Market Share by Region in 2018
Table Global Osteoarthritis Drugs Revenue (Million USD) by Region (2014-2019)
Table Global Osteoarthritis Drugs Revenue Market Share by Region (2014-2019)
Figure Global Osteoarthritis Drugs Revenue Market Share by Region (2014-2019)
Figure Global Osteoarthritis Drugs Revenue Market Share by Region in 2018
Figure Global Osteoarthritis Drugs Production (MT) Growth Rate (2014-2019)
Table Global Osteoarthritis Drugs Production (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Figure North America Osteoarthritis Drugs Production (MT) Growth Rate (2014-2019)
Table North America Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Europe Osteoarthritis Drugs Production (MT) Growth Rate (2014-2019)
Table Europe Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure China Osteoarthritis Drugs Production (MT) Growth Rate (2014-2019)
Table China Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Japan Osteoarthritis Drugs Production (MT) Growth Rate (2014-2019)
Table Japan Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Global Osteoarthritis Drugs Consumption (MT) Market by Region (2014-2019)
Table Global Osteoarthritis Drugs Consumption Market Share by Region (2014-2019)
Figure Global Osteoarthritis Drugs Consumption Market Share by Region (2014-2019)
Figure Global Osteoarthritis Drugs Consumption Market Share by Region in 2018
Figure North America Osteoarthritis Drugs Consumption Growth Rate (2014-2019) (MT)
Figure Europe Osteoarthritis Drugs Consumption Growth Rate (2014-2019) (MT)
Figure China Osteoarthritis Drugs Consumption Growth Rate (2014-2019) (MT)
Figure Japan Osteoarthritis Drugs Consumption Growth Rate (2014-2019) (MT)
Table Global Osteoarthritis Drugs Production (MT) by Type (2014-2019)
Table Global Osteoarthritis Drugs Production Share by Type (2014-2019)
Figure Production Market Share of Osteoarthritis Drugs by Type (2014-2019)
Figure Production Market Share of Osteoarthritis Drugs by Type in 2018
Table Global Osteoarthritis Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Osteoarthritis Drugs Revenue Share by Type (2014-2019)
Figure Revenue Share of Osteoarthritis Drugs by Type (2014-2019)
Figure Revenue Market Share of Osteoarthritis Drugs by Type in 2018
Table Global Osteoarthritis Drugs Price (USD/Kg) by Type (2014-2019)
Figure Global Osteoarthritis Drugs Production Growth by Type (2014-2019) (MT)
Table Global Osteoarthritis Drugs Consumption (MT) by Application (2014-2019)
Table Global Osteoarthritis Drugs Consumption Market Share by Application (2014-2019)
Figure Global Osteoarthritis Drugs Consumption Market Share by Applications (2014-2019)
Figure Global Osteoarthritis Drugs Consumption Market Share by Application in 2018
Table Global Osteoarthritis Drugs Consumption Growth Rate by Application (2014-2019)
Figure Global Osteoarthritis Drugs Consumption Growth Rate by Application (2014-2019)
Table Johnson & Johnson Osteoarthritis Drugs Production Sites and Area Served
Table Johnson & Johnson Product Introduction, Application and Specification
Table Johnson & Johnson Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Johnson & Johnson Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure Johnson & Johnson Osteoarthritis Drugs Production Market Share (2014-2019)
Figure Johnson & Johnson Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table Johnson & Johnson Main Business and Markets Served
Table Pfizer Osteoarthritis Drugs Production Sites and Area Served
Table Pfizer Product Introduction, Application and Specification
Table Pfizer Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Pfizer Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure Pfizer Osteoarthritis Drugs Production Market Share (2014-2019)
Figure Pfizer Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table Pfizer Main Business and Markets Served
Table Eli Lilly Osteoarthritis Drugs Production Sites and Area Served
Table Eli Lilly Product Introduction, Application and Specification
Table Eli Lilly Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Eli Lilly Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure Eli Lilly Osteoarthritis Drugs Production Market Share (2014-2019)
Figure Eli Lilly Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table Eli Lilly Main Business and Markets Served
Table Abbott Osteoarthritis Drugs Production Sites and Area Served
Table Abbott Product Introduction, Application and Specification
Table Abbott Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Abbott Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure Abbott Osteoarthritis Drugs Production Market Share (2014-2019)
Figure Abbott Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table Abbott Main Business and Markets Served
Table GlaxoSmithKline Osteoarthritis Drugs Production Sites and Area Served
Table GlaxoSmithKline Product Introduction, Application and Specification
Table GlaxoSmithKline Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure GlaxoSmithKline Osteoarthritis Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Main Business and Markets Served
Table Sanofi Osteoarthritis Drugs Production Sites and Area Served
Table Sanofi Product Introduction, Application and Specification
Table Sanofi Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Sanofi Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure Sanofi Osteoarthritis Drugs Production Market Share (2014-2019)
Figure Sanofi Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table Sanofi Main Business and Markets Served
Table Flexion Therapeutics Osteoarthritis Drugs Production Sites and Area Served
Table Flexion Therapeutics Product Introduction, Application and Specification
Table Flexion Therapeutics Osteoarthritis Drugs Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Figure Flexion Therapeutics Osteoarthritis Drugs Production Growth Rate (2014-2019)
Figure Flexion Therapeutics Osteoarthritis Drugs Production Market Share (2014-2019)
Figure Flexion Therapeutics Osteoarthritis Drugs Revenue Market Share (2014-2019)
Table Flexion Therapeutics Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoarthritis Drugs
Figure Manufacturing Process Analysis of Osteoarthritis Drugs
Figure Osteoarthritis Drugs Industrial Chain Analysis
Table Osteoarthritis Drugs Distributors List
Table Osteoarthritis Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Osteoarthritis Drugs Production (MT) and Growth Rate Forecast (2019-2025)
Figure Global Osteoarthritis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Osteoarthritis Drugs Price and Trend Forecast (2019-2025)
Table Global Osteoarthritis Drugs Production (MT) Forecast by Region (2019-2025)
Figure Global Osteoarthritis Drugs Production Market Share Forecast by Region (2019-2025)
Figure North America Osteoarthritis Drugs Production (MT) and Growth Rate Forecast (2019-2025)
Figure North America Osteoarthritis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Osteoarthritis Drugs Production (MT) and Growth Rate Forecast (2019-2025)
Figure Europe Osteoarthritis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Osteoarthritis Drugs Production (MT) and Growth Rate Forecast (2019-2025)
Figure China Osteoarthritis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Osteoarthritis Drugs Production (MT) and Growth Rate Forecast (2019-2025)
Figure Japan Osteoarthritis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Osteoarthritis Drugs Consumption (MT) Forecast by Regions (2019-2025)
Figure Global Osteoarthritis Drugs Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Osteoarthritis Drugs Consumption (MT) Growth Rate Forecast (2019-2025)
Figure Europe Osteoarthritis Drugs Consumption (MT) Growth Rate Forecast (2019-2025)
Figure China Osteoarthritis Drugs Consumption (MT) Growth Rate Forecast (2019-2025)
Figure Japan Osteoarthritis Drugs Consumption (MT) Growth Rate Forecast (2019-2025)
Table Global Osteoarthritis Drugs Production (MT) Forecast by Type (2019-2025)
Figure Global Osteoarthritis Drugs Production (MT) Forecast by Type (2019-2025)
Table Global Osteoarthritis Drugs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Osteoarthritis Drugs Revenue Market Share Forecast by Type (2019-2025)
Table Global Osteoarthritis Drugs Price (USD/Kg) Forecast by Type (2019-2025)
Table Global Osteoarthritis Drugs Consumption (MT) Forecast by Application (2019-2025)
Figure Global Osteoarthritis Drugs Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 



Contact Us

U.S.A :  +1-415-871-0703

UK :  +44-203-289-4040

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.